Company profile

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows:
  • medical applications (82.1%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors;
  • industrial applications (17.9%).
The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (38.1%), North America (38.4%), Asia/Pacific (17.7%) and Latin America (5.8%).

Source: Cofisem - Last Update: 02 Aug 2019
Key Executives
Chairman and Chief Executive Officer Alexandre Mérieux
Company Secretary Michel Baguenault
Chief Financial Officer Guillaume Bouhours
HR and Communication Director Valérie Leyldé
Source: Cofisem - Last Update: 02 Aug 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 2.421.300 2.288.200 2.103.200 1.964.600 1.698.400
Income from ordinary activities 2.421.300 2.288.200 2.103.200 1.964.600 1.698.400
Operating income 343.700 314.900 282.500 194.900 203.600
Cost (net) of financial indebtedness -18.500 -16.200 -17.100 -24.700 -14.600
Equity-accounted companies' contribution to results 200 -400 -200 -300 -300
Net profit from discontinued activities
Net income 255.500 237.500 179.200 110.300 135.500
Net income (Group share) 256.600 238.100 179.100 110.500 134.900
Fiscal year end 12,18 12,17 12,16 12,15 12,14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 02 Aug 2019
Shareholder information
Institut Mérieux 58,90 %
Free float 32,92 %
GIMD 5,10 %
Treasury stock 0,48 %
Employees 0,47 %
Source: Cofisem - Last Update: 13 May 2019

Address

bioMérieux

376 Chemin de l'Orme
FR-69280 Marcy l'Etoile
France
Source: Cofisem - Last Update: 02 Aug 2019

Contact

Source: Cofisem - Last Update: 02 Aug 2019